{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:16:35Z","timestamp":1784200595484,"version":"3.55.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371850"],"award-info":[{"award-number":["82371850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Research Program of Anhui","award":["AHWJ2024BAc20031"],"award-info":[{"award-number":["AHWJ2024BAc20031"]}]},{"name":"Distinguished Young Scholar of Anhui Provincial Department of Education","award":["2024AH020008"],"award-info":[{"award-number":["2024AH020008"]}]},{"name":"Provincial Clinical Medical Research Translational Special Project","award":["202527c10020053"],"award-info":[{"award-number":["202527c10020053"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0502003"],"award-info":[{"award-number":["2023ZD0502003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic dysfunction-associated steatohepatitis (MASH), formerly called NASH, is a progressive form of fatty liver disease closely linked to metabolic dysregulation. It has become a leading cause of liver failure and liver transplantation worldwide. Despite its growing clinical significance, there is currently no centralized, publicly accessible, cross-cohort and cross-species transcriptomic database specifically dedicated to MASH. To address this gap, we developed MASH-GA (MASH\u2014Genomic Atlas; https:\/\/mashga.com), the first and only database in the fatty liver research field that systematically integrates transcriptomic data across human cohorts and mouse models. MASH-GA contains 45 human transcriptomic datasets (2740 samples) from 17 countries and 126 mouse datasets (1950 samples) covering major MASH models. The platform provides a range of unique features, including integrated weighted gene coexpression network analysis (WGCNA), cross-model classification and comparison of mouse datasets, multigene correlation analysis and pairwise coexpression exploration, and interactive visualizations (e.g. boxplots and correlation plots). Human and mouse data are presented in separate, intuitively navigable modules. As the only standardized, multicohort, cross-species MASH transcriptomic database currently available, MASH-GA enables reproducible data exploration, informed model selection, and the identification of regulatory modules. It is therefore a valuable resource for researchers in hepatology, metabolic disease, and systems biology. Database URL: \u00a0https:\/\/mashga.com<\/jats:p>","DOI":"10.1093\/database\/baag013","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:44:14Z","timestamp":1772196254000},"source":"Crossref","is-referenced-by-count":0,"title":["MASH-GA: a manually curated cross-species transcriptomic database for metabolic-associated steatohepatitis"],"prefix":"10.1093","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9812-8384","authenticated-orcid":false,"given":"Yong","family":"Wang","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University Department of Hepatobiliary Surgery, , Hefei, Anhui ,","place":["China"]},{"name":"MOE Innovation Center for Basic Research in Tumor Immunotherapy , Hefei, Anhui ,","place":["China"]},{"name":"Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy , Hefei, Anhui ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ding","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University Department of Hepatobiliary Surgery, , Hefei, Anhui ,","place":["China"]},{"name":"MOE Innovation Center for Basic Research in Tumor Immunotherapy , Hefei, Anhui ,","place":["China"]},{"name":"Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy , Hefei, Anhui ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beicheng","family":"Sun","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University Department of Hepatobiliary Surgery, , Hefei, Anhui ,","place":["China"]},{"name":"MOE Innovation Center for Basic Research in Tumor Immunotherapy , Hefei, Anhui ,","place":["China"]},{"name":"Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy , Hefei, Anhui ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiang","family":"Xu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University Department of Hepatobiliary Surgery, , Hefei, Anhui ,","place":["China"]},{"name":"MOE Innovation Center for Basic Research in Tumor Immunotherapy , Hefei, Anhui ,","place":["China"]},{"name":"Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy , Hefei, Anhui ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiting","family":"Zheng","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University Department of Hepatobiliary Surgery, , Hefei, Anhui ,","place":["China"]},{"name":"MOE Innovation Center for Basic Research in Tumor Immunotherapy , Hefei, Anhui ,","place":["China"]},{"name":"Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy , Hefei, Anhui ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University Department of Hepatobiliary Surgery, , Hefei, Anhui ,","place":["China"]},{"name":"MOE Innovation Center for Basic Research in Tumor Immunotherapy , Hefei, Anhui ,","place":["China"]},{"name":"Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy , Hefei, Anhui ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0096-0875","authenticated-orcid":false,"given":"Jian","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University Department of Hepatobiliary Surgery, , Hefei, Anhui ,","place":["China"]},{"name":"MOE Innovation Center for Basic Research in Tumor Immunotherapy , Hefei, Anhui ,","place":["China"]},{"name":"Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy , Hefei, Anhui ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanghui","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University Department of Hepatobiliary Surgery, , Hefei, Anhui ,","place":["China"]},{"name":"MOE Innovation Center for Basic Research in Tumor Immunotherapy , Hefei, Anhui ,","place":["China"]},{"name":"Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy , Hefei, Anhui ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyao","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University Department of Hepatobiliary Surgery, , Hefei, Anhui ,","place":["China"]},{"name":"MOE Innovation Center for Basic Research in Tumor Immunotherapy , Hefei, Anhui ,","place":["China"]},{"name":"Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy , Hefei, Anhui ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University Department of Hepatobiliary Surgery, , Hefei, Anhui ,","place":["China"]},{"name":"MOE Innovation Center for Basic Research in Tumor Immunotherapy , Hefei, Anhui ,","place":["China"]},{"name":"Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy , Hefei, Anhui ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"2026071607023954900_bib1","doi-asserted-by":"publisher","first-page":"1116861","DOI":"10.3389\/fcvm.2023.1116861","article-title":"The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease","volume":"10","author":"Finney","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026071607023954900_bib2","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"2026071607023954900_bib3","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"2026071607023954900_bib4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/ajg.2017.5","article-title":"Prevalence of nonalcoholic steatohepatitis-associated cirrhosis in the United States: an analysis of national health and nutrition examination survey data","volume":"112","author":"Kabbany","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2026071607023954900_bib5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease\u2014a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"2026071607023954900_bib6","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"2026071607023954900_bib7","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"The Lancet"},{"key":"2026071607023954900_bib8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"2026071607023954900_bib9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43935-8","article-title":"GREIN: an interactive web platform for re-analyzing GEO RNA-seq data","volume":"9","author":"Mahi","year":"2019","journal-title":"Sci Rep"},{"key":"2026071607023954900_bib10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/bioinformatics\/bty721","article-title":"ImaGEO: integrative gene expression meta-analysis from GEO database","volume":"35","author":"Toro-Dom\u00ednguez","year":"2019","journal-title":"Bioinformatics"},{"key":"2026071607023954900_bib11","doi-asserted-by":"publisher","first-page":"W207","DOI":"10.1093\/nar\/gkab366","article-title":"eVITTA: a web-based visualization and inference toolbox for transcriptome analysis","volume":"49","author":"Cheng","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2026071607023954900_bib12","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A researcher\u2019s guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat Metab"},{"key":"2026071607023954900_bib13","doi-asserted-by":"publisher","first-page":"15791","DOI":"10.3390\/ijms232415791","article-title":"Genetic and diet-induced animal models for non-alcoholic fatty liver disease (NAFLD) research","volume":"23","author":"Flessa","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026071607023954900_bib14","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3390\/cells10071805","article-title":"Diet-induced models of non-alcoholic fatty liver disease: food for thought on sugar, fat, and cholesterol","volume":"10","author":"Eng","year":"2021","journal-title":"Cells"},{"key":"2026071607023954900_bib15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J Hepatol"},{"key":"2026071607023954900_bib16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1152\/japplphysiol.00683.2020","article-title":"Barriers in translating preclinical rodent exercise metabolism findings to human health","volume":"130","author":"Fuller","year":"2021","journal-title":"J Appl Physiol"},{"key":"2026071607023954900_bib17","doi-asserted-by":"publisher","first-page":"100260","DOI":"10.1016\/j.jlr.2022.100260","article-title":"The cholesteryl ester transfer protein (CETP) raises cholesterol levels in the brain","volume":"63","author":"Oestereich","year":"2022","journal-title":"J Lipid Res"},{"key":"2026071607023954900_bib18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1194\/jlr.M081836","article-title":"Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice","volume":"59","author":"Linden","year":"2018","journal-title":"J Lipid Res"},{"key":"2026071607023954900_bib19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"2026071607023954900_bib20","doi-asserted-by":"publisher","first-page":"eaba4448","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"key":"2026071607023954900_bib21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/hep.26661","article-title":"Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease","volume":"59","author":"Moylan","year":"2014","journal-title":"Hepatology"},{"key":"2026071607023954900_bib22","doi-asserted-by":"publisher","first-page":"G462","DOI":"10.1152\/ajpgi.00358.2018","article-title":"Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals","volume":"316","author":"Suppli","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2026071607023954900_bib23","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/biom12060824","article-title":"NAFLD: mechanisms, treatments, and biomarkers","volume":"12","author":"Nassir","year":"2022","journal-title":"Biomolecules"},{"key":"2026071607023954900_bib24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026071607023954900_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41586-024-08317-9","article-title":"FBP1 controls liver cancer evolution from senescent MASH hepatocytes","volume":"637","author":"Gu","year":"2025","journal-title":"Nature"}],"container-title":["Database"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/database\/article-pdf\/doi\/10.1093\/database\/baag013\/69016338\/baag013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/database\/article-pdf\/doi\/10.1093\/database\/baag013\/69016338\/baag013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:02:45Z","timestamp":1784199765000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/database\/article\/doi\/10.1093\/database\/baag013\/8572081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1093\/database\/baag013","relation":{},"ISSN":["1758-0463"],"issn-type":[{"value":"1758-0463","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"baag013"}}